Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

545
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
545
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

3.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.6K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

2.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.5K
Coagulation01:09

Coagulation

3.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.2K
Disorders of Hemostasis01:24

Disorders of Hemostasis

638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

2.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hyperacute Interleukin-1β Production and Neutrophil Extracellular Trap Formation in the Cerebral Circulation of Stroke Patients with Large Vessel Occlusion.

Annals of neurology·2026
Same author

Extracellular traps from myeloid cells as therapeutic targets in traumatic heterotopic ossification.

Science translational medicine·2026
Same author

Genomic and phenotypic characterization of a multidrug-resistant Streptococcus pneumoniae 19 F ST320 isolate from a pediatric SARS-CoV-2 case in Yogyakarta, Indonesia.

Scientific reports·2026
Same author

Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signaling.

bioRxiv : the preprint server for biology·2026
Same author

European Research Council-funded grant: drivers of thrombo-inflammation.

European heart journal·2026
Same author

<i>Pneumo</i>Wiki: a pan-genome-based database for the pathogen <i>Streptococcus pneumoniae</i>.

Microbiology spectrum·2026

相关实验视频

Updated: May 10, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

由XII因子驱动的凝血会捕捉细菌感染.

Katrin F Nickel1,2, Anne Jämsä3, Sandra Konrath1

  • 1Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

The Journal of experimental medicine
|April 22, 2025
PubMed
概括
此摘要是机器生成的。

由XII因子 (FXII) 驱动的血液凝结可以通过捕获病原体来防止细菌感染. 缺少FXII会使感染恶化,这表明它在天生的免疫力和宿主防御中起着至关重要的作用.

更多相关视频

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

12.2K

相关实验视频

Last Updated: May 10, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

12.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 血液学 血液学 血液学
  • 微生物学 微生物学

背景情况:

  • 血液凝固对于静血至关重要,但与血栓形成有关.
  • 第十二因子 (FXII) 是一种潜在的抗凝剂点,但其生理作用尚不清楚.
  • FXII启动凝血,独立于血液静止.

研究的目的:

  • 研究FXII驱动的凝血在对抗细菌感染的宿主防御中的生理作用.
  • 为了确定FXII是否影响先天免疫和病原体清除.

主要方法:

  • 使用缺乏FXII (F12-/-) 的小鼠来研究肺炎链球菌和金黄色葡萄球菌感染.
  • 评估了细菌负担,全身传播,死亡率和纤维素沉积.
  • 研究了血卡利克林和FXII基质因子XI的作用.

主要成果:

  • 在F12-/-小鼠中,S. pneumoniae和S. aureus感染的严重程度增加.
  • 缺乏FXII导致纤维素沉积受损,壁受损,细菌逃逸.
  • 细菌长链聚酸盐被确定为FXII的激活剂.

结论:

  • 由FXII驱动的凝血在对抗细菌感染的天生的免疫力中起着保护作用.
  • 针对抗凝固的FXII需要仔细考虑,因为它在宿主防御中的作用.
  • 研究结果表明,FXII对于有效制病原体和限制感染传播至关重要.